The Drugs for Neglected Diseases initiative (DNDi) and the Japanese pharmaceutical company Eisai Co., Ltd. have signed an agreement to proceed with the clinical development of Eisai's anti-fungal ...

This news release is available in Japanese. [Basel, Switzerland , Tokyo, Japan- 10 September 2015] The Drugs for Neglected Diseases initiative (DNDi) and the Japanese pharmaceutical company Eisai ...

The manuscript shares the results of early work to screen 800 diverse, drug-like molecules for active compounds against the causative pathogen of eumycetoma, which yielded several promising new hits.

Eumycetoma is a chronic fungal infection usually striking the tissue of the feet, leading to swelling and the formation of disfiguring 'grains' that may warrant amputation of the foot. It is endemic ...

Mycetoma infection is caused by bacteria actinomycetoma or fungi eumycetoma, from thorns pricking people walking barefoot. Children make up about 20-25% of all mycetoma patients.